Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

Background: Long-acting injectable (LAI) aripiprazole was found to be efficacious in schizophrenia. In common clinical practice, the use of LAIs is often restricted to chronic patients with frequent relapses and poor adherence. Recently, some investigators advanced the idea of early LAI use also in...

Full description

Bibliographic Details
Main Authors: Gloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, Emanuela Amici, Filippo Perrini, Gemma Callovini, Alfonso Carannante, Georgios D. Kotzalidis, Sergio De Filippis
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Psychiatry
Subjects:
schizophrenia
first episode psychosis
positive symptoms
negative symptoms
long-acting injectable antipsychotics
aripiprazole
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00935/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2019.00935/full

Similar Items